Dr. Shover, a postdoctoral research fellow at Stanford University worked with fellow researchers Corey Davis, Sanford Gordon, and Keith Humphreys to buck a cannabis industry pearl of conventional wisdom; the oft-cited, often-sloganeered study by Marcus Bachhuber that found a positive correlation between medical cannabis states and a decrease in opioid overdose deaths from 1999-2010.

Positive T.A. Nelson, a former seven-term senator and the current Commissioner of Agriculture of the U.S. Virgin Islands tried several times to pass legislation legalizing medical cannabis before he was ultimately successful this past January. After a long-fought battle, Gov. Albert Bryan Jr. finally signed into law the Virgin Islands Medicinal Cannabis Care Act.

In a somewhat uniquely American way, opioid use disorder has become a marketing boon for the emerging cannabis industry. Advocates and industrialists alike have focus-grouped America’s deadliest epidemic into a modern-day Pepsi Challenge; a double-blind, peer-reviewed taste test where four-out-of-five addicts prefer medical marijuana.